Imexon April 12, 2017 Imexon Trade Name Orphan Indication Pancreatic adenocarcinoma USA Market Approval USA USA Designation Date 2003-11-01 00:00:00 Sponsor AmpliMed Corporation;4380 North Campbell Avenue, Suite 205;Tucson, Arizona, 85718
